Skip to main content
Effect of Commonly Used Pediatric Antibiotics on Gut Microbial Diversity in Preschool Children in Burkina Faso: A Randomized Clinical Trial.
- Author(s): Oldenburg, Catherine E;
- Sié, Ali;
- Coulibaly, Boubacar;
- Ouermi, Lucienne;
- Dah, Clarisse;
- Tapsoba, Charlemagne;
- Bärnighausen, Till;
- Ray, Kathryn J;
- Zhong, Lina;
- Cummings, Susie;
- Lebas, Elodie;
- Lietman, Thomas M;
- Keenan, Jeremy D;
- Doan, Thuy
- et al.
Published Web Locationhttps://doi.org/10.1093/ofid/ofy289
BackgroundExposure to antibiotics may result in alterations to the composition of intestinal microbiota. However, few trials have been conducted, and observational studies are subject to confounding by indication. We conducted a randomized controlled trial to determine the effect of 3 commonly used pediatric antibiotics on the intestinal microbiome in healthy preschool children.
MethodsChildren aged 6-59 months were randomized (1:1:1:1) to a 5-day course of 1 of 3 antibiotics, including amoxicillin (25 mg/kg/d twice-daily doses), azithromycin (10 mg/kg dose on day 1 and then 5 mg/kg once daily for 4 days), cotrimoxazole (240 mg once daily), or placebo. Rectal swabs were obtained at baseline and 5 days after the last dose and were processed using 16S rRNA gene sequencing. The prespecified primary outcome was inverse Simpson's α-diversity index.
ResultsPost-treatment Simpson's diversity was significantly different across the 4 arms (P = .003). The mean Simpson's α-diversity among azithromycin-treated children was significantly lower than in placebo-treated children (6.6; 95% confidence interval [CI], 5.5-7.8; vs 9.8; 95% CI, 8.7-10.9; P = .0001). Diversity in children treated with amoxicillin (8.3; 95% CI, 7.0-9.6; P = .09) or cotrimoxazole (8.3; 95% CI, 8.2-9.7; P = .08) was not significantly different than placebo.
ConclusionsAzithromycin affects the composition of the pediatric intestinal microbiome. The effect of amoxicillin and cotrimoxazole on microbiome composition was less clear.
Clinical trials registrationclinicaltrials.gov NCT03187834.
For improved accessibility of PDF content, download the file to your device.